Legal Notice, Service Ownership and Intellectual Property
Public legal framework for UESE Precision Bio AI, service ownership, information responsibilities and intellectual-property rights.
Regulatory and governance references
- Italian Civil Code and applicable B2B/digital-services law
- Italian Legislative Decree 70/2003 on electronic commerce, where applicable
- Italian/EU intellectual-property and database law
References indicate the design framework and must be verified against the current legislation, implementing measures, national law and the parties’ actual roles at implementation time.
1. Provider Identity and Service Scope
UESE ITALIA S.p.A., registered office at Piazza Trivulziana 4/A, 20126 Milan (MI), Italy, VAT/tax code IT04398760274, REA MI 2679515, owns the website and UESE Precision Bio AI platform. This notice governs access to public information and distinguishes institutional communication, technical documentation, commercial proposals and customer-specific contractual commitments.
The responsible legal entity must be unambiguously identifiable. Corporate details, contact channels and the relevant privacy role are kept separate from the commercial product name; a division or internal business unit does not change legal ownership unless expressly stated.
Public statements must be interpreted in context and do not create commitments beyond those formally assumed. Scientific or regulatory information must be checked against current law and the organisation’s specific scenario before reliance.
For enterprise deployments, the decision should be translated into a RACI matrix, verifiable evidence, acceptance criteria, technical controls and periodic review; exceptions must be approved, reasoned, time-limited and traceable.
2. B2B Nature and Professional Audience
UESE ITALIA S.p.A., registered office at Piazza Trivulziana 4/A, 20126 Milan (MI), Italy, VAT/tax code IT04398760274, REA MI 2679515, owns the website and UESE Precision Bio AI platform. This notice governs access to public information and distinguishes institutional communication, technical documentation, commercial proposals and customer-specific contractual commitments.
Access is intended for organisations and professionals acting in the course of their activities. The customer must ensure that users, researchers and collaborators are authorised and appropriately trained; involvement of consumers, patients or non-professional users requires a separate contractual and regulatory assessment.
Public statements must be interpreted in context and do not create commitments beyond those formally assumed. Scientific or regulatory information must be checked against current law and the organisation’s specific scenario before reliance.
In healthcare or multi-centre projects, the requirement should be linked to the protocol, decision record, DPIA or security file where relevant, avoiding any assumption that a technical configuration replaces legal or scientific assessment.
3. Platform Ownership and Distinctive Signs
UESE ITALIA S.p.A., registered office at Piazza Trivulziana 4/A, 20126 Milan (MI), Italy, VAT/tax code IT04398760274, REA MI 2679515, owns the website and UESE Precision Bio AI platform. This notice governs access to public information and distinguishes institutional communication, technical documentation, commercial proposals and customer-specific contractual commitments.
Use of UESE names, marks, logos, screenshots or references in external communications is subject to brand rules and, where required, written approval. A collaboration, demonstration or integration does not permit claims of endorsement, certification or healthcare approval that do not exist.
Public statements must be interpreted in context and do not create commitments beyond those formally assumed. Scientific or regulatory information must be checked against current law and the organisation’s specific scenario before reliance.
Compliance is continuous: changes to purpose, data, suppliers, engines, hosting, integrations or law require impact assessment and, where needed, updates to contracts, controls, instructions and documentation.
4. Software Intellectual Property
UESE ITALIA S.p.A., registered office at Piazza Trivulziana 4/A, 20126 Milan (MI), Italy, VAT/tax code IT04398760274, REA MI 2679515, owns the website and UESE Precision Bio AI platform. This notice governs access to public information and distinguishes institutional communication, technical documentation, commercial proposals and customer-specific contractual commitments.
The UESE Precision Bio AI platform, its proprietary source code, application architecture, interfaces, original documentation, trademarks, graphical elements and components specifically developed for the product are owned by UESE ITALIA S.p.A., without prejudice to open-source libraries, standards, third-party components or technologies, which remain subject to the rights and licences of their respective owners. The Project Lead is dr. Giuseppe Izzo. The customer receives only the contractual right of use; unauthorised reverse engineering, systematic extraction, sublicensing or exploitation is prohibited to the extent permitted by law.
Public statements must be interpreted in context and do not create commitments beyond those formally assumed. Scientific or regulatory information must be checked against current law and the organisation’s specific scenario before reliance.
UESE retains evidence proportionate to function and risk. The customer organisation remains responsible for its authorisations, protocols, legal bases and healthcare or scientific decisions beyond the service scope entrusted to UESE.
5. Content, Documentation and Databases
UESE ITALIA S.p.A., registered office at Piazza Trivulziana 4/A, 20126 Milan (MI), Italy, VAT/tax code IT04398760274, REA MI 2679515, owns the website and UESE Precision Bio AI platform. This notice governs access to public information and distinguishes institutional communication, technical documentation, commercial proposals and customer-specific contractual commitments.
Documentation is version controlled and may be updated to reflect technical, scientific or regulatory change. Databases imported by the customer remain subject to the rights and restrictions applicable to their source; the existence of an import feature does not grant UESE rights over the content or guarantee that the source may lawfully be reused.
Public statements must be interpreted in context and do not create commitments beyond those formally assumed. Scientific or regulatory information must be checked against current law and the organisation’s specific scenario before reliance.
For enterprise deployments, the decision should be translated into a RACI matrix, verifiable evidence, acceptance criteria, technical controls and periodic review; exceptions must be approved, reasoned, time-limited and traceable.
6. Open-Source Components and Third-Party Licences
UESE ITALIA S.p.A., registered office at Piazza Trivulziana 4/A, 20126 Milan (MI), Italy, VAT/tax code IT04398760274, REA MI 2679515, owns the website and UESE Precision Bio AI platform. This notice governs access to public information and distinguishes institutional communication, technical documentation, commercial proposals and customer-specific contractual commitments.
Third-party components remain subject to their own licences. UESE maintains technical attribution for distributed components; the customer must separately assess licences and terms for external tools it chooses to integrate, including bioinformatics engines, models and scientific databases.
Public statements must be interpreted in context and do not create commitments beyond those formally assumed. Scientific or regulatory information must be checked against current law and the organisation’s specific scenario before reliance.
In healthcare or multi-centre projects, the requirement should be linked to the protocol, decision record, DPIA or security file where relevant, avoiding any assumption that a technical configuration replaces legal or scientific assessment.
7. Scientific Information and No Medical Advice
UESE ITALIA S.p.A., registered office at Piazza Trivulziana 4/A, 20126 Milan (MI), Italy, VAT/tax code IT04398760274, REA MI 2679515, owns the website and UESE Precision Bio AI platform. This notice governs access to public information and distinguishes institutional communication, technical documentation, commercial proposals and customer-specific contractual commitments.
No public information, classification, score or RUO output may be interpreted as individual medical advice. Diagnosis and treatment remain the exclusive responsibility of qualified healthcare professionals acting within their competence, authorisations and applicable clinical evidence.
Public statements must be interpreted in context and do not create commitments beyond those formally assumed. Scientific or regulatory information must be checked against current law and the organisation’s specific scenario before reliance.
Compliance is continuous: changes to purpose, data, suppliers, engines, hosting, integrations or law require impact assessment and, where needed, updates to contracts, controls, instructions and documentation.
8. Research Use Only and Current Intended Purpose
UESE ITALIA S.p.A., registered office at Piazza Trivulziana 4/A, 20126 Milan (MI), Italy, VAT/tax code IT04398760274, REA MI 2679515, owns the website and UESE Precision Bio AI platform. This notice governs access to public information and distinguishes institutional communication, technical documentation, commercial proposals and customer-specific contractual commitments.
The current intended purpose must be reflected in product materials, manuals and onboarding. Any change introducing a medical, diagnostic, prognostic, predictive or therapeutic purpose requires a new software qualification analysis and, where applicable, an MDR/IVDR pathway and reassessment under the AI Act.
RTO and RPO, if offered, must be expressly stated in the SLA and aligned with the architecture. Without executed values they cannot be inferred from public material; disaster recovery and application restoration should be tested periodically where required by the continuity plan.
UESE retains evidence proportionate to function and risk. The customer organisation remains responsible for its authorisations, protocols, legal bases and healthcare or scientific decisions beyond the service scope entrusted to UESE.
9. Links, Integrations and Third-Party Resources
UESE ITALIA S.p.A., registered office at Piazza Trivulziana 4/A, 20126 Milan (MI), Italy, VAT/tax code IT04398760274, REA MI 2679515, owns the website and UESE Precision Bio AI platform. This notice governs access to public information and distinguishes institutional communication, technical documentation, commercial proposals and customer-specific contractual commitments.
Integrations must be inventoried and authorised. The customer must determine what data may leave its environment, which credentials are used, who governs APIs and which terms apply to the recipient; tokens, endpoints and secrets must be managed with least privilege and appropriate rotation.
Public statements must be interpreted in context and do not create commitments beyond those formally assumed. Scientific or regulatory information must be checked against current law and the organisation’s specific scenario before reliance.
For enterprise deployments, the decision should be translated into a RACI matrix, verifiable evidence, acceptance criteria, technical controls and periodic review; exceptions must be approved, reasoned, time-limited and traceable.
10. Accuracy, Updates and Availability of Information
UESE ITALIA S.p.A., registered office at Piazza Trivulziana 4/A, 20126 Milan (MI), Italy, VAT/tax code IT04398760274, REA MI 2679515, owns the website and UESE Precision Bio AI platform. This notice governs access to public information and distinguishes institutional communication, technical documentation, commercial proposals and customer-specific contractual commitments.
Public information is descriptive and may be updated where it does not alter existing contractual commitments. Guaranteed specifications, service levels and features must be found in executed documents; healthcare or regulatory decisions must not rely on promotional material.
Metrics must be chosen for the intended purpose rather than reduced to a single aggregate number. Robustness and cybersecurity include anomalous inputs, dependencies, availability, manipulation and failure behaviour; thresholds and fallback conditions should be defined before operational use.
Availability is calculated using the formula, scope and measurement period defined in the SLA, excluding only agreed categories. Application outage, planned maintenance, third-party failure and degraded functionality must be distinguished; measurement should rely on verifiable sources.
In healthcare or multi-centre projects, the requirement should be linked to the protocol, decision record, DPIA or security file where relevant, avoiding any assumption that a technical configuration replaces legal or scientific assessment.
11. Trademark Use and Public Communications
UESE ITALIA S.p.A., registered office at Piazza Trivulziana 4/A, 20126 Milan (MI), Italy, VAT/tax code IT04398760274, REA MI 2679515, owns the website and UESE Precision Bio AI platform. This notice governs access to public information and distinguishes institutional communication, technical documentation, commercial proposals and customer-specific contractual commitments.
Use of UESE names, marks, logos, screenshots or references in external communications is subject to brand rules and, where required, written approval. A collaboration, demonstration or integration does not permit claims of endorsement, certification or healthcare approval that do not exist.
Public statements must be interpreted in context and do not create commitments beyond those formally assumed. Scientific or regulatory information must be checked against current law and the organisation’s specific scenario before reliance.
Compliance is continuous: changes to purpose, data, suppliers, engines, hosting, integrations or law require impact assessment and, where needed, updates to contracts, controls, instructions and documentation.
12. Responsibilities of the Using Organisation
UESE ITALIA S.p.A., registered office at Piazza Trivulziana 4/A, 20126 Milan (MI), Italy, VAT/tax code IT04398760274, REA MI 2679515, owns the website and UESE Precision Bio AI platform. This notice governs access to public information and distinguishes institutional communication, technical documentation, commercial proposals and customer-specific contractual commitments.
Public statements must be interpreted in context and do not create commitments beyond those formally assumed. Scientific or regulatory information must be checked against current law and the organisation’s specific scenario before reliance.
UESE retains evidence proportionate to function and risk. The customer organisation remains responsible for its authorisations, protocols, legal bases and healthcare or scientific decisions beyond the service scope entrusted to UESE.
13. Public Website Liability Limitations
UESE ITALIA S.p.A., registered office at Piazza Trivulziana 4/A, 20126 Milan (MI), Italy, VAT/tax code IT04398760274, REA MI 2679515, owns the website and UESE Precision Bio AI platform. This notice governs access to public information and distinguishes institutional communication, technical documentation, commercial proposals and customer-specific contractual commitments.
Users must receive enough information to understand purpose, inputs, nature of scores, material limitations and non-use conditions. The required level of explanation is proportionate to risk and user role; a numerical score without context is not treated as adequate explanation.
Public statements must be interpreted in context and do not create commitments beyond those formally assumed. Scientific or regulatory information must be checked against current law and the organisation’s specific scenario before reliance.
For enterprise deployments, the decision should be translated into a RACI matrix, verifiable evidence, acceptance criteria, technical controls and periodic review; exceptions must be approved, reasoned, time-limited and traceable.
14. Applicable Law, Jurisdiction and Mandatory Rules
UESE ITALIA S.p.A., registered office at Piazza Trivulziana 4/A, 20126 Milan (MI), Italy, VAT/tax code IT04398760274, REA MI 2679515, owns the website and UESE Precision Bio AI platform. This notice governs access to public information and distinguishes institutional communication, technical documentation, commercial proposals and customer-specific contractual commitments.
The governing agreement determines applicable law and jurisdiction to the extent permitted by mandatory rules. Non-derogable powers of supervisory authorities and EU or national provisions that apply regardless of contractual choice remain unaffected.
Public statements must be interpreted in context and do not create commitments beyond those formally assumed. Scientific or regulatory information must be checked against current law and the organisation’s specific scenario before reliance.
In healthcare or multi-centre projects, the requirement should be linked to the protocol, decision record, DPIA or security file where relevant, avoiding any assumption that a technical configuration replaces legal or scientific assessment.
15. Amendments, Versioning and Legal Contacts
UESE ITALIA S.p.A., registered office at Piazza Trivulziana 4/A, 20126 Milan (MI), Italy, VAT/tax code IT04398760274, REA MI 2679515, owns the website and UESE Precision Bio AI platform. This notice governs access to public information and distinguishes institutional communication, technical documentation, commercial proposals and customer-specific contractual commitments.
Public statements must be interpreted in context and do not create commitments beyond those formally assumed. Scientific or regulatory information must be checked against current law and the organisation’s specific scenario before reliance.
Compliance is continuous: changes to purpose, data, suppliers, engines, hosting, integrations or law require impact assessment and, where needed, updates to contracts, controls, instructions and documentation.
For requests concerning data processed within a customer project, UESE may need to direct the data subject to the competent controller. For commercial or technical enquiries, use the dedicated stakeholder form and do not submit patient data.
Request informationWebsite owner and corporate contacts
UESE ITALIA S.p.A. · Piazza Trivulziana 4/A · 20126 Milano (MI) · Italy · P. IVA / C.F. IT04398760274 · REA MI 2679515 · sales@uese.it · +39 02 5656 8416.